Skip to main content

Table 6 Effect of ceramide inhibition on the toxicity of palmitate

From: A hierarchical approach employing metabolic and gene expression profiles to identify the pathways that confer cytotoxicity in HepG2 cells

Treatment C16 Ceramide (pmol/mg protein) LDH released (%)
Control (BSA) 0.63 ± 0.28 * 1.27 ± 0.48 *
Palmitate 24.44 ± 6.39 4.71 ± 1.67
Fumonisin B1 6.80 ± 2.85 * 5.15 ± 1.38
  1. *, significantly lower than palmitate